公开(公告)号：US20170319477A1

公开(公告)日：2017-11-09

申请号：US15660639

申请日：2017-07-26

Applicant: Daniel R. BURNETT ,  Peter G. EDELMAN

Inventor： Daniel R. BURNETT ,  Peter G. EDELMAN

IPC: A61K9/00 ,  A61F5/00 ,  A61K38/16 ,  A61K31/78 ,  A61K31/765 ,  A61K31/715 ,  A61K31/7088 ,  A61K9/48 ,  A61K9/28 ,  A61K9/20 ,  A61K38/38

CPC classification number: A61K9/0065 ,  A61F5/003 ,  A61F5/0036 ,  A61K9/2022 ,  A61K9/2027 ,  A61K9/205 ,  A61K9/2063 ,  A61K9/2833 ,  A61K9/4866 ,  A61K31/7088 ,  A61K31/715 ,  A61K31/765 ,  A61K31/78 ,  A61K38/16 ,  A61K38/38 ,  A61K2800/546

Abstract: Provided are ingestible polymeric formulations for the reduction of gastric volume in the treatment of overweight patients, and methods of use thereof. One method involves ingesting one or more ingestible tablets comprising cross-linked polymers formed in a packed mass within the one or more ingestible tablets into a stomach of the subject, wherein the cross-linked polymers comprise a polymer hydrogel comprising carboxymethylcellulose and a carboxylic acid; disintegrating an acid-sensitive gelatin coating such that the coating disintegrates in the gastric fluid and the cross-linked polymers disperse in the stomach; and maintaining the reduction in gastric volume such that a sensation of fullness is induced in the subject without releasing a drug which induces the sensation.

公开(公告)号：US20170281062A1

公开(公告)日：2017-10-05

申请号：US15629337

申请日：2017-06-21

Applicant: Daniel R. BURNETT ,  Evan S. LUXON

Inventor： Daniel R. BURNETT ,  Evan S. LUXON

IPC: A61B5/145 ,  A61B5/1459 ,  A61B5/00

CPC classification number: A61B5/14532 ,  A61B5/0031 ,  A61B5/14507 ,  A61B5/1459 ,  A61B5/4839 ,  A61B5/6852 ,  A61B5/6858 ,  A61B5/6867 ,  A61B5/6874

Abstract: Use of the peritoneal space provides a more direct tracking of blood glucose, capturing faster glucose kinetics, avoiding membrane/encapsulation effects, having less lag time and lag time variability, and eliminating the effect of variations in skin temperature, cardiac output, and body position during sleep. A peritoneal sensor system may be implanted within the peritoneal space and may generally include a sensor/sampler portion, which is implanted in the peritoneal space, and a control portion/controller, which may be implanted elsewhere, such as subcutaneously, or may be external to the patient.

公开(公告)号：US20170143880A1

公开(公告)日：2017-05-25

申请号：US15422323

申请日：2017-02-01

Applicant: Evan S. LUXON ,  Daniel R. BURNETT ,  Mark ZIEGLER

Inventor： Evan S. LUXON ,  Daniel R. BURNETT ,  Mark ZIEGLER

IPC: A61M1/00 ,  A61M27/00

Abstract: Disclosed is a chest drainage system which reduces or eliminates pooling of blood/liquid and/or clogging/clotting in the drainage tube. Generally, the chest drainage system continuously monitors chest tube status and clears pooled liquid when necessary to restore negative pressure to the chest. The system may include a valve device which is located between the patient's chest tube and drainage tube and may be used with any standard chest tube. The chest drainage system also includes a controller for monitoring the pressure at or near the valve device and/or at or near the suction device, and possibly a pump for assisting in clearance of pooled liquid and/or clots. The controller may also control the valve device and/or suction device in response to pressure signals.

公开(公告)号：US20120165788A1

公开(公告)日：2012-06-28

申请号：US13309434

申请日：2011-12-01

Applicant: Daniel R. BURNETT ,  Gregory W. HALL ,  Jordan T. BAJOR ,  Winfield Scott FISHER ,  Tibor Laszlo HITES

Inventor： Daniel R. BURNETT ,  Gregory W. HALL ,  Jordan T. BAJOR ,  Winfield Scott FISHER ,  Tibor Laszlo HITES

IPC: A61M25/00

CPC classification number: A61F2/95 ,  A61B17/12099 ,  A61B17/12159 ,  A61B2017/12054 ,  A61B2017/12059 ,  A61B2017/12081 ,  A61B2090/037 ,  A61F2/88 ,  A61F2/97 ,  A61F5/0079 ,  A61F2002/044 ,  A61F2002/9511

Abstract: Apparatus for delivering a medical device to a location in a patient's body includes an elongate catheter body having a proximal end and a distal end, a pod coupled with the distal end of the catheter body and adapted to house the medical device during delivery to the location and to open to release the medical device, and at least one distal actuator coupled with at least one of the pod and the medical device. The distal actuator is adapted to promote opening of the pod. A method involves advancing a pod at the distal end of an elongate catheter to the location within the body and activating an actuator coupled with the pod and/or the medical device to cause the pod to open. Opening the pod releases the medical device.

Abstract translation: 用于将医疗装置递送到患者体内的位置的装置包括具有近端和远端的细长导管主体，与导管主体的远端联接的适配器，用于在输送到位置期间容纳医疗装置 并且打开以释放所述医疗装置，以及至少一个与所述容器和所述医疗装置中的至少一个联接的远端致动器。 远侧致动器适于促进荚的打开。 一种方法包括将细长导管的远端处的囊推进到体内的位置，并启动与荚和/或医疗装置连接的致动器以使荚打开。 打开荚释放医疗器械。

公开(公告)号：US20090118757A1

公开(公告)日：2009-05-07

申请号：US12351686

申请日：2009-01-09

Applicant: Daniel R. BURNETT ,  Greg HALL ,  Roxanne RICHMAN ,  David A. GALLUP ,  Annette CAMPBELL-WHITE

Inventor： Daniel R. BURNETT ,  Greg HALL ,  Roxanne RICHMAN ,  David A. GALLUP ,  Annette CAMPBELL-WHITE

IPC: A61M29/00 ,  A61B17/08 ,  A61N1/00

CPC classification number: A61B17/12022 ,  A61B5/036 ,  A61B5/073 ,  A61B5/14539 ,  A61B17/12036 ,  A61B17/12099 ,  A61B17/12136 ,  A61B17/12172 ,  A61B17/1219 ,  A61B2017/00004 ,  A61B2017/00557 ,  A61B2017/12054 ,  A61B2017/12086 ,  A61F5/003 ,  A61F5/0036 ,  A61F5/0079

Abstract: Methods, devices and systems facilitate intermittent and/or partial obstruction of a pyloric valve. Devices generally include a support portion for preventing the device from passing through the pyloric valve and a tissue engagement portion for contacting tissue adjacent the pyloric valve to obstruct the valve. Some embodiments also include a positioning member extending from the tissue engagement portion for helping position the device for obstructing the valve. A retaining member may optionally be included on the distal end of the positioning member for further maintaining a position of the device in the stomach. Some embodiments are deliverable into the stomach through the esophagus, either by swallowing or through a delivery tube or catheter. Some embodiments are fully reversible. Some embodiments self-expand within the stomach, while others are inflated or otherwise expanded.

Abstract translation: 方法，装置和系统促进幽门阀的间歇性和/或局部阻塞。 装置通常包括用于防止装置通过幽门阀的支撑部分和用于接触幽门阀附近的组织以阻塞瓣膜的组织接合部分。 一些实施例还包括从组织接合部分延伸的定位构件，用于帮助定位用于阻塞阀的装置。 可以可选地将保持构件包括在定位构件的远端上，以进一步保持装置在胃中的位置。 一些实施例可通过吞咽或通过输送管或导管通过食道输送到胃中。 一些实施例是完全可逆的。 一些实施例在胃内自扩张，而另一些实施例被膨胀或以其他方式扩张。